Cargando…

Non-alcoholic Fatty Liver Disease, Cardio-metabolic Syndrome and Hypertension: One Concept Fits Multi-systemic Presentations

Detalles Bibliográficos
Autor principal:	Kim, Mi-Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390723/ https://www.ncbi.nlm.nih.gov/pubmed/32725977 http://dx.doi.org/10.4070/kcj.2020.0217

Ejemplares similares

Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
por: El Hadi, Hamza, et al.
Publicado: (2019)

Which One Is More Important, Obesity or Cardio Metabolic Risk Factors?
por: Hosseinpanah, Farhad
Publicado: (2012)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease
por: Zoncapè, Mirko, et al.
Publicado: (2022)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Alcohol Consumption, Hypertension, and Cardiovascular Health Across the Life Course: There Is No Such Thing as a One‐Size‐Fits‐All Approach
por: Bell, Steven
Publicado: (2018)

Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021)

Risk factors and cardio-metabolic outcomes associated with metabolic-associated fatty liver disease in childhood
por: de Groot, Jasmin, et al.
Publicado: (2023)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline
por: Sung, Ki-Chul, et al.
Publicado: (2012)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

Repurposing Cardio-Metabolic Drugs to Fight Covid19
por: Battistoni, Allegra, et al.
Publicado: (2021)

Cardio-Renal Metabolic Syndrome: Interdisciplinary Diagnostic Methods
por: Bungau, Simona Gabriela
Publicado: (2023)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

The growing burden of non-alcoholic fatty liver disease on mortality
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

Optimal diagnosis and management of non-alcoholic fatty liver disease
Publicado: (2022)

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2022)

One Carbon Metabolism and S-Adenosylmethionine in Non-Alcoholic Fatty Liver Disease Pathogenesis and Subtypes
por: Fernández-Ramos, David, et al.
Publicado: (2022)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Fatty Liver Disease: Metabolic, Genetic, or Both?
por: Zoller, Heinz, et al.
Publicado: (2020)

Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
por: Eshraghian, Ahad
Publicado: (2017)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Managing non‐alcoholic fatty liver disease in diabetes: Challenges and opportunities
por: Lee, Chi‐Ho, et al.
Publicado: (2016)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
por: Shim, Ju Hyun
Publicado: (2020)

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Cardio-oncology: Concepts and practice
por: Cubbon, Richard M., et al.
Publicado: (2016)

Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
por: Grander, Christoph, et al.
Publicado: (2023)

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

Editorial: The Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) and Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: Why the American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL) Consensus Process is Not Representative
por: Fouad, Yasser Mahrous, et al.
Publicado: (2022)

Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances
por: Kassi, Eva, et al.
Publicado: (2023)

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
por: Sinn, Dong Hyun, et al.
Publicado: (2014)

Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease
por: O'Brien, Alastair
Publicado: (2022)

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Teng, Margaret L. P., et al.
Publicado: (2022)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
por: Teng, Margaret LP, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
por: Uehara, Tatsuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s1rm40q2lfmo98alp5mf12r5ia